Xenetic Biosciences Stock Price on November 12, 2024
| XBIO Stock | USD 4.11 0.07 1.73% |
Below is the normalized historical share price chart for Xenetic Biosciences extending back to June 19, 2012. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Xenetic Biosciences stands at 4.11, as last reported on the 29th of December, with the highest price reaching 4.11 and the lowest price hitting 3.90 during the day.
If you're considering investing in Xenetic Stock, it is important to understand the factors that can impact its price. As of now, Xenetic Stock is somewhat reliable. Xenetic Biosciences shows Sharpe Ratio of 0.0028, which attests that the company had a 0.0028% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Xenetic Biosciences, which you can use to evaluate the volatility of the company. Please check out Xenetic Biosciences' Downside Deviation of 3.88, mean deviation of 3.23, and Market Risk Adjusted Performance of (0.30) to validate if the risk estimate we provide is consistent with the expected return of 0.0119%.
At this time, Xenetic Biosciences' Total Stockholder Equity is very stable compared to the past year. As of the 29th of December 2024, Liabilities And Stockholders Equity is likely to grow to about 18 M, while Common Stock Total Equity is likely to drop 7,499. . As of the 29th of December 2024, Price Earnings To Growth Ratio is likely to grow to 0.03, while Price To Sales Ratio is likely to drop 1.97. Xenetic Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 30th of June 2014 | 200 Day MA 4.0032 | 50 Day MA 4.0223 | Beta 2.263 |
Xenetic |
Sharpe Ratio = 0.0028
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | XBIO |
Estimated Market Risk
| 4.29 actual daily | 38 62% of assets are more volatile |
Expected Return
| 0.01 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.0 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Xenetic Biosciences is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Xenetic Biosciences by adding Xenetic Biosciences to a well-diversified portfolio.
Price Book 0.9008 | Enterprise Value Ebitda 1.0257 | Price Sales 2.5143 | Shares Float 1.2 M | Wall Street Target Price 40 |
Related Headline
ZyVersa Therapeutics Headline on 12th of November 2024
ZyVersa Therapeutics, Inc. Short Interest Update by thelincolnianonline.com
ZyVersa Therapeutics, Inc. was the recipient of a significant growth in short interest in October. As of October 31st, there was short interest totalling 45,500 shares, a growth of 369.1 percent from the October 15th total of 9,700 shares. Based on an average daily volume of 1,170,000 shares, the days-to-cover ratio
Xenetic Biosciences Valuation on November 12, 2024
It is possible to determine the worth of Xenetic Biosciences on a given historical date. On November 12, 2024 Xenetic was worth 4.4 at the beginning of the trading date compared to the closed value of 4.13. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Xenetic Biosciences stock. Still, in general, we apply an absolute valuation method to find Xenetic Biosciences' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Xenetic Biosciences where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Xenetic Biosciences' related companies.
| Open | High | Low | Close | Volume | |
| 4.38 | 4.60 | 3.89 | 3.95 | 104,630 | |
11/12/2024 | 4.40 | 4.43 | 4.00 | 4.13 | 103,244 |
| 4.01 | 4.11 | 3.62 | 3.65 | 53,107 |
| Backtest Xenetic Biosciences | | | Xenetic Biosciences History | | | Xenetic Biosciences Valuation | Previous | Next |
Xenetic Biosciences Trading Date Momentum on November 12, 2024
| On November 13 2024 Xenetic Biosciences was traded for 3.65 at the closing time. The top price for the day was 4.11 and the lowest listed price was 3.62 . The trading volume for the day was 53.1 K. The trading history from November 13, 2024 was a factor to the next trading day price decrease. The trading price change against the next closing price was 11.62% . The trading price change against the current closing price is 2.66% . |
Xenetic Biosciences Fundamentals Correlations and Trends
By evaluating Xenetic Biosciences' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Xenetic Biosciences' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Xenetic financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Xenetic Biosciences Stock history
Xenetic Biosciences investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Xenetic is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Xenetic Biosciences will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Xenetic Biosciences stock prices may prove useful in developing a viable investing in Xenetic Biosciences
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 1.5 M | 1.6 M | |
| Net Loss | -6.5 M | -6.8 M |
Xenetic Biosciences Quarterly Net Working Capital |
|
Xenetic Biosciences Stock Technical Analysis
Xenetic Biosciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Xenetic Biosciences Period Price Range
Low | December 29, 2024
| High |
0.00 | 0.00 |
Xenetic Biosciences cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Xenetic Biosciences December 29, 2024 Market Strength
Market strength indicators help investors to evaluate how Xenetic Biosciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Xenetic Biosciences shares will generate the highest return on investment. By undertsting and applying Xenetic Biosciences stock market strength indicators, traders can identify Xenetic Biosciences entry and exit signals to maximize returns
Xenetic Biosciences Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Xenetic Biosciences' price direction in advance. Along with the technical and fundamental analysis of Xenetic Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Xenetic to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.035 | |||
| Jensen Alpha | 0.1529 | |||
| Total Risk Alpha | 0.0161 | |||
| Sortino Ratio | 0.0311 | |||
| Treynor Ratio | (0.31) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Xenetic Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. To learn how to invest in Xenetic Stock, please use our How to Invest in Xenetic Biosciences guide.You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Xenetic Biosciences. If investors know Xenetic will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Xenetic Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.66) | Revenue Per Share 1.638 | Quarterly Revenue Growth 0.116 | Return On Assets (0.29) | Return On Equity (0.49) |
The market value of Xenetic Biosciences is measured differently than its book value, which is the value of Xenetic that is recorded on the company's balance sheet. Investors also form their own opinion of Xenetic Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Xenetic Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Xenetic Biosciences' market value can be influenced by many factors that don't directly affect Xenetic Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Xenetic Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Xenetic Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Xenetic Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.